Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: J Viral Hepat. 2011 May 13;18(10):e447–e452. doi: 10.1111/j.1365-2893.2011.01466.x

Table 3. Laboratory trends of the two HBV carriers with lamivudine resistance.

Participant HBV DNA level
(IU/ml)
HBV Mutations Serum ALT
(IU/L)
HIV RNA level
(copies/ml)
22 Month 0 280,000 None 24 614,000
Month 6 86 None 9 78
Month 12 288 A200V + M204I 150 34
Month 18 478,000,000 A200V + M204I 80 2

27 Month 0 430,000,000 None 34 194,300
Month 6 3,407 M204I 39 26
Month 12 2,027 M204I 28 14
Month 18 576 M204I 38 84

HBV, hepatitis B virus. HIV, human immunodeficiency virus. ALT, alanine aminotransferase.